Unknown NA INTERVENTIONAL 1-arm NCT02484573

Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Interventions Propanolol

Updated 9 times since 2017 Last updated: Jan 29, 2019 Started: May 31, 2015 Primary completion: Jan 31, 2020 Completion: Aug 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Liver Cirrhoses and is currently ongoing. Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran leads this study, which shows 9 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Feb 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Feb 2021 [monthly]

Recruiting NA
Feb 2019 — Jan 2021 [monthly]

Recruiting NA

Status: Unknown Status → Recruiting

▶ Show 4 earlier versions

Dec 2018 — Feb 2019 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Dec 2018 [monthly]

Recruiting NA
Feb 2017 — Jun 2018 [monthly]

Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Data source: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mexico City, Mexico